CASC18: A Non-Protein-Coding RNA Molecule with Potential as a Cancer Treatment

Target Name: CASC18

NCBI ID: G101929110

CASC18

Other Name(s): Cancer susceptibility candidate 18 (non-protein coding) | Cancer susceptibility 18 (non-protein coding) | cancer susceptibility 18 | CASC18 variant 1 | Cancer susceptibility 18, transcript variant 1

CASC18: A Non-Protein-Coding RNA Molecule with Potential as a Cancer Treatment

Cancer Susceptibility Candidate 18 (CASC18) is a non-protein coding RNA molecule that has been identified as a potential drug target for cancer. It is a small molecule that is expressed in various tissues and cells, including the brain, heart, and gastrointestinal tract.CASC18 has been shown to play a role in cell signaling pathways, and its levels have been correlated with the development and progression of certain types of cancer.

One of the key challenges in the search for new cancer treatments is the difficulty of identifying the underlying causes of cancer. Cancer is a complex disease that is influenced by a variety of genetic and environmental factors, and it can be difficult to identify the specific genetic changes that are driving the disease. However, some researchers believe that CASC18 may be a useful drug target because it is involved in a number of different signaling pathways that are involved in cancer development.

CASC18 is a non-coding RNA molecule that is expressed in various tissues and cells. It is composed of a small number of exons that are involved in the regulation of gene expression.CASC18 is regulated by a variety of factors, including the DNA methylation state, histone modifications, and small molecules.

One of the key functions of CASC18 is its role in cell signaling pathways. It is a component of several different signaling pathways that are involved in the regulation of cell growth, differentiation, and survival. For example, one of the most well-studied signaling pathways that is regulated by CASC18 is the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cell growth and survival, and is a key factor in the development of many types of cancer.

Another signaling pathway that is regulated by CASC18 is the NF-kappa-B signaling pathway. This pathway is involved in the regulation of inflammation and immune responses, and is also involved in the development of cancer.

CASC18 has also been shown to play a role in the regulation of cell adhesion. Adhesion is the process by which cells stick together and form tissues, and is an important factor in the development of cancer.CASC18 is involved in the regulation of cell adhesion by promoting the stickiness of cells to adhesion molecules on the surface of the cell.

In addition to its role in cell signaling pathways, CASC18 has also been shown to be involved in the regulation of gene expression. It has been shown to play a role in the regulation of the expression of several genes that are involved in cell growth, differentiation, and survival.

One of the challenges in the search for new cancer treatments is the difficulty of identifying the underlying causes of cancer. Cancer is a complex disease that is influenced by a variety of genetic and environmental factors, and it can be difficult to identify the specific genetic changes that are driving the disease. However, some researchers believe that CASC18 may be a useful drug target because it is involved in a number of different signaling pathways that are involved in cancer development.

CASC18 is a small molecule that is expressed in various tissues and cells, including the brain, heart, and gastrointestinal tract. It is composed of a small number of exons that are involved in the regulation of gene expression.CASC18 is regulated by a variety of factors, including the DNA methylation state, histone modifications, and small molecules.

One of the key functions of CASC18 is its role in cell signaling pathways. It is a component of several different signaling pathways that are involved in the regulation of cell growth, differentiation, and survival. For example, one of the most well-studied signaling pathways that is regulated by CASC18 is the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cell growth and survival, and is a key factor in the development of many types of cancer.

Another signaling pathway that is regulated by CASC18 is the NF-kappa-B signaling pathway. This pathway is involved in the regulation of inflammation and immune responses, and is also involved in the development of cancer.

Protein Name: Cancer Susceptibility 18

The "CASC18 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CASC18 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets